Tci Wealth Advisors, Inc. United Therapeutics Corp Transaction History

Tci Wealth Advisors, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$212.99 - $276.17 $4,898 - $6,351	-23 Reduced 30.67%	52 $11,000
Q4 2022 Feb 06, 2023	BUY	$205.95 - $280.43 $4,736 - $6,449	23 Added 44.23%	75 $20,000
Q3 2022 Nov 08, 2022	BUY	$203.3 - $244.17 $813 - $976	4 Added 8.33%	52 $11,000
Q1 2022 Apr 29, 2022	SELL	$166.16 - $213.96 $18,609 - $23,963	-112 Reduced 70.0%	48 $9,000
Q4 2021 Jan 24, 2022	BUY	$184.32 - $216.08 $4,976 - $5,834	27 Added 20.3%	160 $35,000
Q3 2021 Oct 29, 2021	BUY	$179.86 - $214.88 $6,474 - $7,735	36 Added 37.11%	133 $25,000
Q1 2021 Apr 29, 2021	BUY	$153.94 - $174.85 $7,543 - $8,567	49 Added 102.08%	97 $16,000
Q4 2020 Jan 21, 2021	BUY	$101.87 - $151.79 $407 - $607	4 Added 9.09%	48 $7,000
Q3 2020 Oct 20, 2020	BUY	$99.9 - $121.13 $4,395 - $5,329	44 New	44 $4,000

676

42.1M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.3B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.